| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-164-7117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:4-(((4-((4-Chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide methanesulfonate
CAS:332013-26-0
Purity:99% Package:25mg;50mg;100mg;250mg Remarks:BD01194927
|
| Company Name: |
Kaixin Chemical (Hong Kong) Limited
|
| Tel: |
010-88886666-01 13112345678 |
| Email: |
loyson@tcypharm.com |
| Products Intro: |
Product Name:Telatinib mesylate
CAS:332013-26-0
Purity:98% Package:1G;10G;100G
|
Telatinib mesylate manufacturers
- Telatinib mesylate
-
- $43.00 / 2mg
-
2025-10-27
- CAS:332013-26-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Telatinib mesylate Basic information |
| Product Name: | Telatinib mesylate | | Synonyms: | Telatinib mesylate;4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide methanesulfonate;Telatinib mesylate (Bay 57-9352 mesylate) | | CAS: | 332013-26-0 | | MF: | C21H20ClN5O6S | | MW: | 505.93 | | EINECS: | | | Product Categories: | | | Mol File: | 332013-26-0.mol |  |
| | Telatinib mesylate Chemical Properties |
| form | Solid | | color | White to off-white |
| | Telatinib mesylate Usage And Synthesis |
| Uses | Telatinib mesylate (Bay 57-9352 mesylate) is a potent and orally active VEGFR2, VEGFR3, PDGFα, and c-Kit inhibitor with IC50s of 6 nM, 4 nM, 15 nM and 1 nM, respectively[1]. | | in vivo | Telatinib (15 mg/kg; oral dministration; every 2nd and 3rd day; total 12 times; male athymic NCR (nu/nu) nude mice) with Doxorubicin (1.8 mg/kg) significantly decreases the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model[2]. | Animal Model: | Male athymic NCR (nu/nu) nude mice (13-15 g, age 4-5 weeks) injected with H460 and H460/MX20 cells[2] | | Dosage: | 15 mg/kg | | Administration: | Oral dministration; every 2nd and 3rd day; total 12 times | | Result: | With Doxorubicin (1.8 mg/kg) significantly decreased the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model. |
| | IC 50 | VEGFR2: 6 nM (IC50); VEGFR3: 4 nM (IC50); PDGFRα: 15 nM (IC50); c-Kit: 1 nM (IC50) | | References | [1] Steeghs N, et al.Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.Clin Cancer Res. 2008 Jun 1;14(11):3470-6. DOI:10.1158/1078-0432.CCR-07-5050
[2] [2] Sodani K, et al. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochem Pharmacol. 2014 May 1;89(1):52-61. DOI:10.1016/j.bcp.2014.02.012 |
| | Telatinib mesylate Preparation Products And Raw materials |
|